Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-15

Clinical Trial Update: Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether oral caffeine intake influences the severity of acute migraine attacks, assessed by Visual Analog Scale, in patients a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)

Snippet

Sponsor: Ain Shams University | Conditions: Migraine, Migraine Disease | Phase 4 | Status: RECRUITING